Serving leading biopharmaceutical companies globally:

Dow
Merck
Boehringer Ingelheim
Mallinckrodt
Harvard Business School
Medtronic

Make Better Decisions, Faster

Start Trial: 5 days for $50

Bundle: All Modules

34,500 17,250/year

  • Get all modules for one low price
➤ Select Options or, request an invoice

82% Pick This

Pharmaceutical Drugs

8,500/year

  • US & International Patents
  • Active and Expired Patents in 134 Countries, Regulatory Protections and Exclusivities
  • Anticipate Generic Entry
  • Loss-of-Exclusivity Dates, Paragraph IV Challenges, Tentative Approvals, Authorized Generics, and more…
  • Find Commercial Opportunities
  • Single Source Off-Patent Drugs, Search Patents by Dosage Form / Therapeutic Class
  • Drug Sourcing
  • API Vendors, Finished Product Suppliers, First Generic Entrants

 

Biologic Drugs

4,000/year

  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Finished Product Suppliers
  • Manufacturers

 

Drugs In Development

6,000/year

  • Drug Candidates in Phase I-III Clinical Trials
  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Clinical Trials
  • API Vendors

US Drug Patent Litigation

6,000/year

  • US District Court Cases
  • Patent Infringement, Contract Disputes, Antitrust, etc.
  • Patent Trial and Appeal Board
  • PTAB inter partes review, post-grant review

US Drug Prices

5,000/year

  • Brand vs. Generic Drug Price Gap
  • Find generic entry opportunities
  • Average Pharmacy Cost
  • Set reasonable launch prices
  • Best-Available Price
  • See price ranges

US Top Drug Sales

5,000/year

  • Annual Gross Revenues & Units Sold
  • Prescription Payment Methods
  • Self-Paid, Private Insurance, Medicaid, etc.
  • Pharmacy Locations & Types
  • Mail-order, Drugstore, in-Clinic, etc.

Bundle: All Modules

4,150 1,900/monthly

  • Get all modules for one low price
➤ Select Options or, request an invoice

82% Pick This

Pharmaceutical Drugs

1,000/monthly

  • US & International Patents
  • Active and Expired Patents in 134 Countries, Regulatory Protections and Exclusivities
  • Anticipate Generic Entry
  • Loss-of-Exclusivity Dates, Paragraph IV Challenges, Tentative Approvals, Authorized Generics, and more…
  • Find Commercial Opportunities
  • Single Source Off-Patent Drugs, Search Patents by Dosage Form / Therapeutic Class
  • Drug Sourcing
  • API Vendors, Finished Product Suppliers, First Generic Entrants

 

Biologic Drugs

450/monthly

  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Finished Product Suppliers
  • Manufacturers

 

Drugs In Development

750/monthly

  • Drug Candidates in Phase I-III Clinical Trials
  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Clinical Trials
  • API Vendors

US Drug Patent Litigation

750/monthly

  • US District Court Cases
  • Patent Infringement, Contract Disputes, Antitrust, etc.
  • Patent Trial and Appeal Board
  • PTAB inter partes review, post-grant review

US Drug Prices

600/monthly

  • Brand vs. Generic Drug Price Gap
  • Find generic entry opportunities
  • Average Pharmacy Cost
  • Set reasonable launch prices
  • Best-Available Price
  • See price ranges

US Top Drug Sales

600/monthly

  • Annual Gross Revenues & Units Sold
  • Prescription Payment Methods
  • Self-Paid, Private Insurance, Medicaid, etc.
  • Pharmacy Locations & Types
  • Mail-order, Drugstore, in-Clinic, etc.

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Clients in 67 Countries